5
Pharmaceutical preparations for the treatment of cardiovascular diseases, pharmaceutical preparations for the treatment of depression, pharmaceutical preparations for the treatment of pain, pharmaceutical preparations for the treatment of anxiety, pharmaceutical preparations for the treatment of diabetes, pharmaceutical preparations for the treatment of cardiovascular-related conditions, pharmaceutical preparations for the treatment of depression-related conditions, pharmaceutical preparations for the treatment of pain-related conditions, pharmaceutical preparations for the treatment of anxiety-related conditions, pharmaceutical preparations for the treatment of diabetes-related conditions, pharmaceutical preparations for the treatment of Attention Deficit Hyperactivity Disorder (ADHD), pharmaceutical preparations for the treatment of panic disorder, pharmaceutical preparations for the treatment of Post-Traumatic Stress Disorder (PTSD), pharmaceutical preparations for the treatment of Parkinson’s Disease, pharmaceutical preparations for the treatment of dementia, pharmaceutical preparations for the treatment of amnesia, pharmaceutical preparations for the treatment of autism, pharmaceutical preparations for the treatment of drug intoxication, pharmaceutical preparations for the treatment of premature ejaculation, pharmaceutical preparations for the treatment of Hyperlipidemia, pharmaceutical preparations for the treatment of Obsessive Compulsive Disorder, pharmaceutical preparations for the treatment of obesity